US OptionsDetailed Quotes

ORGO241220C5000

Watchlist
  • 0.05
  • 0.000.00%
15min DelayClose Nov 26 16:00 ET
0.00High0.00Low
Intraday
  • 5D
  • Daily

News

Comments

    Jaguar8
    Jaguar8
    Nov 22 15:06
    NEWS
    $Organogenesis (ORGO.US)$
    Organogenesis Expands Manufacturing Capacity to Support Future Growth
    Organogenesis Holdings (Nasdaq: ORGO) announced plans to expand its manufacturing capacity through a long-term lease of a 122,000-square foot state-of-the-art biomanufacturing facility in Smithfield, Rhode Island. The regenerative medicine company, which focuses on Advanced Wound Care and Surgical and Sports Medicine markets, will maintain its existing operations across multiple locations includi...
    Jaguar8
    Jaguar8
    Nov 12 15:03
    NEWS
    $Organogenesis (ORGO.US)$
    Organogenesis Holdings Inc. Announces $130 Million Private Placement Offering of Series A Convertible Preferred Stock
    Jaguar8
    Jaguar8
    Nov 11 16:05
    NEWS
    $Organogenesis (ORGO.US)$
    Organogenesis Reports Positive Interim Analysis of Second Phase 3 Clinical Trial of ReNu for Knee Osteoarthritis
    Organogenesis Holdings (ORGO) announced positive interim analysis results from its second Phase 3 clinical trial of ReNu for knee osteoarthritis treatment. The analysis, covering 50% of 474 planned patients with moderate to severe knee OA, focused on the 6-month primary endpoint. The independent Data Monitoring Committee recommended proceeding without modi...
    Jaguar8
    Jaguar8
    Oct 1 15:08
    NEWS
    $Organogenesis (ORGO.US)$
    Organogenesis Announces Publication of Randomized Clinical Trial Results Demonstrating the Safety and Efficacy of NuShield for Diabetic Foot Ulcers
    • Robust 218-patient RCT demonstrates statistically superior frequency of wound closure at 12 weeks compared to standard of care (p=.04)
    • Organogenesis believes published study satisfies requirements for Medicare coverage under proposed Local Coverage Determination (LCDs)
    CANTON, Mass., Oct. 01, 2024 (GLOBE NEWSWIRE) ...
Read more